as 11-14-2024 4:00pm EST
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Founded: | 2003 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | 28.7M | IPO Year: | 2018 |
Target Price: | $1.00 | AVG Volume (30 days): | 3.4M |
Analyst Decision: | Hold | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.18 | EPS Growth: | N/A |
52 Week Low/High: | $0.24 - $2.27 | Next Earning Date: | 11-13-2024 |
Revenue: | $36,579,000 | Revenue Growth: | 16.08% |
Revenue Growth (this year): | -0.09% | Revenue Growth (next year): | 21.35% |
BNGO Breaking Stock News: Dive into BNGO Ticker-Specific Updates for Smart Investing
GuruFocus.com
16 hours ago
Motley Fool
21 hours ago
GlobeNewswire
a day ago
GlobeNewswire
7 days ago
GlobeNewswire
14 days ago
MT Newswires
14 days ago
GlobeNewswire
14 days ago
GlobeNewswire
14 days ago
The information presented on this page, "BNGO Bionano Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.